(Press-News.org) CHAPEL HILL, N.C. – Over the last two decades, scientists have come to understand that the genetic code held within DNA represents only part of the blueprint of life. The rest comes from specific patterns of chemical tags that overlay the DNA structure, determining how tightly the DNA is packaged and how accessible certain genes are to be switched on or off.
As researchers have uncovered more and more of these "epigenetic" tags, they have begun to wonder how they are all connected. Now, research from the University of North Carolina School of Medicine has established the first link between the two most fundamental epigenetic tags -- histone modification and DNA methylation -- in humans.
The study, which was published Sept. 30, 2012 by the journal Nature Structural & Molecular Biology, implicates a protein called UHRF1 in the maintenance of these epigenetic tags. Because the protein has been found to be defective in cancer, the finding could help scientists understand not only how microscopic chemical changes can ultimately affect the epigenetic landscape but also give clues to the underlying causes of disease and cancer.
"There's always been the suspicion that regions marked by DNA methylation might be connected to other epigenetic tags like histone modifications, and that has even been shown to be true in model organisms like fungus and plants," said senior study author Brian Strahl, PhD, associate professor of biochemistry and biophysics in the UNC School of Medicine and a member of UNC Lineberger Comprehensive Cancer Center. "But no one has been able to make that leap in human cells. It's been controversial in terms of whether or not there's really a connection. We have shown there is."
Strahl, along with his postdoctoral fellow Scott Rothbart, honed in on this discovery by using a highly sophisticated technique developed in his lab known as next generation peptide arrays. First the Strahl lab generated specific types of histone modifications and dotted them on tiny glass slides called "arrays." They then used these "arrays" to see how histone modifications affected the docking of different proteins. One protein – UHRF1 – stood out because it bound a specific histone modification (lysine 9 methylation on histone H3) in cases where others could not.
Strahl and his colleagues focused the rest of their experiments on understanding the role of UHRF1 binding to this histone modification. They found that while other proteins that dock on this epigenetic tag are ejected during a specific phase of the cell cycle, mitosis, UHRF1 sticks around. Importantly, the protein's association with histones throughout the cell cycle appears to be critical to maintaining another epigenetic tag called DNA methylation. The result was surprising because researchers had previously believed that the maintenance of DNA methylation occurred exclusively during a single step of the cell cycle called DNA replication.
"This role of UHRF1 outside of DNA replication is certainly unexpected, but I think it is just another way of making sure we don't lose information about our epigenetic landscape," said Strahl.
INFORMATION:
The research was funded by the National Institutes of Health and the North Carolina Biotechnology Center.
Study co-authors from UNC were Scott B. Rothbart, PhD, a postdoc in Strahl's lab at UNC; Krzysztof Krajewski, PhD, research assistant professor; and Jorge Y. Martinez, a former student in Strahl's lab.
Scientists find missing link between players in the epigenetic code
2012-10-01
ELSE PRESS RELEASES FROM THIS DATE:
Blocking key protein could halt age-related decline in immune system, Stanford study finds
2012-10-01
STANFORD, Calif. — The older we get, the weaker our immune systems tend to become, leaving us vulnerable to infectious diseases and cancer and eroding our ability to benefit from vaccination. Now Stanford University School of Medicine scientists have found that blocking the action of a single protein whose levels in our immune cells creep steadily upward with age can restore those cells' response to a vaccine.
This discovery holds important long-term therapeutic ramifications, said Jorg Goronzy, MD, PhD, professor of rheumatology and immunology and the senior author of ...
Noninvasive measurement enables use of IFP as potential biomarker for tumor aggressiveness
2012-10-01
PHILADELPHIA — Researchers validated a method of noninvasive imaging that provides valuable information about interstitial fluid pressure of solid tumors and may aid in the identification of aggressive tumors, according to the results of a study published in Cancer Research, a journal of the American Association for Cancer Research.
Many malignant solid tumors generally develop a higher interstitial fluid pressure (IFP) than normal tissue. High IFP in tumors may cause a reduced uptake of chemotherapeutic agents and resistance to radiation therapy. In addition, a high ...
Mayo Clinic physicians ID reasons for high cost of cancer drugs, prescribe solutions
2012-10-01
ROCHESTER, Minn. -- A virtual monopoly held by some drug manufacturers in part because of the way treatment protocols work is among the reasons cancer drugs cost so much in the United States, according to a commentary by two Mayo Clinic physicians in the October issue of the journal Mayo Clinic Proceedings. Value-based pricing is one potential solution, they write.
VIDEO ALERT: Video of Dr. Rajkumar discussing the commentary is posted on the Mayo Clinic News Network.
Cancer care is not representative of a free-market system, and the traditional checks and balances that ...
Republican strength in congress aids super-rich, president's affiliation has no effect
2012-10-01
WASHINGTON, DC, September 27, 2012 — Republican strength in Congress increases the share of income held by the top 1 percent, but the president's political affiliation has no effect, suggests a new study in the October issue of the American Sociological Review that looks at the rise of the super-rich in the United States.
"This points to the central role that Congress has in the legislative process," said study co-author Thomas W. Volscho, an Assistant Professor of Sociology at CUNY-College of Staten Island. "The president has limited ability to make the sort of legislative ...
Patient-led advocacy has changed how US government funds medical research
2012-10-01
WASHINGTON, DC, September 27, 2012 — Patient-led advocacy has created a shift in the way the U.S. government has prioritized funding for medical research, and significantly changed the way policymakers think about who benefits the most from these dollars, a University of Michigan School of Public Health fellow in the Robert Wood Johnson Foundation Scholars in Health Policy Research Program found.
In "Disease Politics and Medical Research Funding: Three Ways Advocacy Shapes Policy," a paper published in the October issue of the American Sociological Review, Rachel Kahn ...
End your child's allergy suffering within 3 years
2012-10-01
ARLINGTON HEIGHTS, Ill. (October 1, 2012) – When children suffer from dust mite induced allergies and asthma, finding relief can seem impossible. While there isn't a complete cure for childhood respiratory allergies, researchers have found that long term control of allergic asthma can occur after only three years of allergy shots.
According to a new study, published in the October issue of Annals of Allergy, Asthma and Immunology, the scientific publication of the American College of Allergy, Asthma and Immunology (ACAAI), long-term relief can be achieved by administering ...
Radiologists develop evidence-based guidelines to help physicians manage patients with low back pain
2012-10-01
According to an article in the October issue of the Journal of the American College of Radiology, radiologists at Emory University Hospital, in Atlanta, and Georgia Health Sciences University, in Augusta, Ga., have developed evidence-based guidelines to assist physicians with the process of managing patients with acute low back pain. Low back pain is one of the most common reasons for visits to physicians in the outpatient setting.
"The approach to the workup and management of low back pain by physicians and other practitioners is inconstant. In fact, there is significant ...
Hidden stroke impairment leaves thousands suffering in silence
2012-10-01
Most people are completely unaware of one of stroke's most common, debilitating but invisible impairments, according to the first awareness survey of its kind in Canada released today at the Canadian Stroke Congress.
Thirty community volunteers trained by the York-Durham Aphasia Centre, a March of Dimes Canada program, collaborated with researchers from two Ontario universities in a survey of 832 adults in southern Ontario. They found that only two per cent of respondents could correctly identify aphasia as a communication disorder affecting the ability to speak, understand, ...
Special Journal issue focuses on radiology's role in health care reform
2012-10-01
To be published online Monday, Oct. 1, a special issue of the Journal of the American College of Radiology will focus on health policy and radiology's role in health care reform. Topics to be covered include utilization management in radiology, clinical decision support, value-based health care payment systems and patient-centered outcomes in imaging. The October health policy issue was guest edited by Ruth Carlos, MD, MS, FACR, and James Rawson, MD, FACR.
"Health care reform will continue to be a central issue in society regardless of the outcome of the election in ...
'Cafeteria diet' hastens stroke risk
2012-10-01
The fat- and sugar-rich Western diet leads to a lifetime of health problems, dramatically increasing the risk of stroke or death at a younger age, according to a study presented today at the Canadian Stroke Congress.
Researchers found that a high-calorie, high-sugar, high-sodium diet nicknamed the 'cafeteria diet' induced most symptoms of metabolic syndrome – a combination of high levels of cholesterol, blood sugar, blood pressure and obesity – in rats after only two months.
The animals were at an age roughly equivalent to 16 to 22 years in humans at the time of disease ...